{"id":"CHEMBL1004","canonicalSmiles":"CN(C)CCOC(C)(c1ccccc1)c1ccccn1","inchiKey":"HCFDWZZGGLSKEP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYLAMINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Decapryn","Doxy-Sleep-Aid","Doxylamine","Unisom"],"crossReferences":{"DailyMed":["doxylamine%20succinate"],"PubChem":["90340822"],"Wikipedia":["Doxylamine"],"drugbank":["DB00366"],"chEBI":["51380"]},"childChemblIds":["CHEMBL1200392"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000544","HP_0002017","MONDO_0005271"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and is indicated for allergic disease and has 3 investigational indications."}
{"id":"CHEMBL1005","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1","inchiKey":"ZTVQQQVZCWLTDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"REMIFENTANIL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GI 87084X","IDS-NR-005","Ramifentanyl","Remifentanil","Remifentanyl","Ultiva","Ultiva-"],"crossReferences":{"DailyMed":["remifentanil%20hydrochloride"],"Wikipedia":["Remifentanil"],"drugbank":["DB00899"],"chEBI":["8802"]},"childChemblIds":["CHEMBL1201120"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0000726","EFO_0003777","EFO_0007486","MONDO_0041052","HP_0012735","EFO_1001905","EFO_0011057","EFO_1000644","EFO_0009267","EFO_0000266","EFO_1000637","MONDO_0024355","EFO_0004253","EFO_0000712","MONDO_0008903","EFO_0005306","EFO_1001062","EFO_0003917","EFO_0003877","EFO_0007490","MONDO_0021233","EFO_0000616","EFO_0004799","HP_0001649","HP_0002093","EFO_0001074","HP_0012532","EFO_0002687","EFO_0005323","EFO_0001645","EFO_0010702","EFO_0001073","EFO_0003843","EFO_0002615","HP_0000713","HP_0001082","EFO_0003890","HP_0002045","EFO_1000391","EFO_0009842","HP_0001336","EFO_0005611","MONDO_0043510","EFO_0003833","EFO_0003918","EFO_0004337","EFO_0005251"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1062","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"DBPWSSGDRRHUNT-CEGNMAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYPROGESTERONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["17.alpha.-hydroxyprogesterone","Hydroxyprogesterone","NSC-15468","U-3096"],"crossReferences":{"PubChem":["144204784","144211847","170466429","26753584","50106362","56422152","8139906","90340864"],"Wikipedia":["17-Hydroxyprogesterone"],"drugbank":["DB14570"],"chEBI":["17252"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1118","canonicalSmiles":"CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1","inchiKey":"KYYIDSXMWOZKMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESVENLAFAXINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desvenlafaxine","Khedezla","Pristiq"],"synonyms":["D-veniz","Desvenlafaxine","Mdd-xr","Newven","O-desmethylvenlafaxine","ODV"],"crossReferences":{"DailyMed":["desvenlafaxine","desvenlafaxine%20succinate"],"Wikipedia":["Desvenlafaxine"],"drugbank":["DB06700"],"chEBI":["83527"]},"childChemblIds":["CHEMBL3989861","CHEMBL1201728"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_1000783","EFO_0004220","EFO_0005687","MONDO_0002050","EFO_1001892","EFO_0008623","MONDO_0002009","EFO_0003761","EFO_1001917","HP_0031217","EFO_0003922"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1180074","canonicalSmiles":"CCCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1","inchiKey":"WNBGYVXHFTYOBY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRISTALKONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Myristalkonium","Myristalkonium cation","Myristalkonium ion","Myristyl-benzalkonium","Zephiramine cation","Zephiramine ion"],"crossReferences":{"PubChem":["124898794"],"drugbank":["DB13774"]},"childChemblIds":["CHEMBL1473396","CHEMBL2361574","CHEMBL421049","CHEMBL112719"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1183040","canonicalSmiles":"Cc1c(CCO)sc[n+]1CCCCCCCCCCCC[n+]1csc(CCO)c1C","inchiKey":"UZPXHZIQHWKNPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBITIAZOLIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albitiazolium cation","Albitiazolium ion","SAR-97276","SAR97276"],"childChemblIds":["CHEMBL520613","CHEMBL276933"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL12","canonicalSmiles":"CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"AAOVKJBEBIDNHE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIAZEPAM","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alupram 10","Alupram 2","Alupram 5","Apozepam","Atensine","Dialar","Dialar fte","Diastat","Diastat acudial","Diazepam","Diazepam intensol","Dizac","E-Pam","Paxel","Q-pam","Relanium","Scriptopam","Serenack","Solis","Stesolid","Tensium","Tranimul","Valclair","Valium","Valrelease","Valtoco","Vivol"],"synonyms":["Ansiolisina","Centrazepam","Diacepin","Diazepam","Diazepam civ","LA III","LA-III","NRL-1","NSC-169897","NSC-77518","Nrl-1","RO 5-2807","RO-5-2807","RO-52807","Servizepam","Tranquase","WY-3467"],"crossReferences":{"DailyMed":["diazepam"],"PubChem":["124893574","144206622","144209656","170464626"],"TG-GATEs":["23"],"Wikipedia":["Diazepam"],"drugbank":["DB00829"],"chEBI":["49575"]},"childChemblIds":["CHEMBL543191"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0008526","MONDO_0005090","EFO_1000877","EFO_0005242","EFO_0006788","EFO_0007498","HP_0000726","EFO_0001358","HP_0001250","EFO_0003843","HP_0000713","EFO_0000546","EFO_0000474","MONDO_0002050","EFO_1000632","HP_0003419","EFO_0005279","EFO_0005230","EFO_1001250","EFO_1001010"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 6 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200613","canonicalSmiles":"Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]","inchiKey":"QGUALMNFRILWRA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"TOLMETIN SODIUM","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1020","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tolectin","Tolectin 600","Tolectin ds","Tolmetin sodium"],"synonyms":["MCN-2559-21-98","NSC-757341","Sodium tolmetin","Tolmetin sodium","Tolmetin sodium anhydrous","Tolmetin sodium dihydrate","Tolmetin sodium salt dihydrate"],"crossReferences":{"DailyMed":["tolmetin%20sodium"],"PubChem":["26748279"],"chEBI":["9619"]},"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0005178"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and is indicated for osteoarthritis and rheumatoid arthritis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200707","canonicalSmiles":"CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(C)=O.Cl","inchiKey":"KZLNXGBVFTWMPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZQUINAMIDE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201250","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emete-con"],"synonyms":["Benzquinamide hcl","Benzquinamide hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1200790","canonicalSmiles":"CCC1(CC)C(=O)NCC(C)C1=O","inchiKey":"SIDLZWOQUZRBRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYPRYLON","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Noludar"],"synonyms":["Methyprylon","NSC-30442"],"crossReferences":{"Wikipedia":["Methyprylon"],"drugbank":["DB01107"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200908","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"BDSYKGHYMJNPAB-LICBFIPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOBETASOL PROPIONATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bryhali","Halobetasol propionate","Lexette","Ultravate"],"synonyms":["21-chloro diflorasone","BMY-30056","CGP-14,458","CGP-14458","Halobetasol","Halobetasol propionate","IDP-122","Jemdel","Ulobetasol","Ulobetasol propionate"],"crossReferences":{"DailyMed":["halobetasol%20propionate"],"PubChem":["144206008"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1001494","EFO_0000701","EFO_0000676","EFO_0000274"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1201001","canonicalSmiles":"CN(CCCl)CCCl.Cl","inchiKey":"QZIQJVCYUQZDIR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MECHLORETHAMINE HYDROCHLORIDE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL427","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mustargen","Valchlor"],"synonyms":["Chlormethine hcl","Chlormethine hydrochloride","Chlormethini hydrochloridum","Hn2 hydrochloride","Mechlorethamine hcl","Mechlorethamine hydrochloride","Mustine","NSC-762","Nitrogen mustard","Nitrogen mustard n-oxide hydrochloride"],"crossReferences":{"DailyMed":["mechlorethamine%20hydrochloride"],"PubChem":["144204721","144207836","170465017","17388852","538248"],"chEBI":["55368"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and is indicated for cutaneous t-cell lymphoma and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201010","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"SYWHXTATXSMDSB-GSLJADNHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUDROCORTISONE ACETATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Astonin","Florinef","Fludrocortisone acetate","Fludrocortone","Panotile"],"synonyms":["Fludrocortisone 21-acetate","Fludrocortisone acetate","Fludrocortisoni acetas","Fluorhydrocortisone acetate","Fluorocortisol acetate","NSC-15186","Scherofluron"],"crossReferences":{"DailyMed":["fludrocortisone%20acetate"],"chEBI":["5102"]},"linkedTargets":{"rows":["ENSG00000151623"],"count":1},"linkedDiseases":{"rows":["MONDO_0015128","Orphanet_64739","MONDO_0002050","EFO_0006834","MONDO_0005180","EFO_0000756","EFO_0005252","EFO_1001176","HP_0031273","Orphanet_181412","Orphanet_418"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for adrenogenital syndrome and primary adrenal insufficiency and has 7 investigational indications."}
{"id":"CHEMBL1201237","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O","inchiKey":"IXHBTMCLRNMKHZ-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBUNOLOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bunolol, (-)-","Bunolol, (s)-","Levobunolol"],"crossReferences":{"DailyMed":["levobunolol%20hydrochloride"],"PubChem":["11112712","11112713"],"Wikipedia":["Levobunolol"],"drugbank":["DB01210"],"chEBI":["6438"]},"childChemblIds":["CHEMBL1201177"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0000516"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for glaucoma."}
{"id":"CHEMBL1201407","canonicalSmiles":"CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\\CCCC(=O)O","inchiKey":"TVHAZVBUYQMHBC-SNHXEXRGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UNOPROSTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Unoprostone"],"crossReferences":{"Wikipedia":["Unoprostone"],"drugbank":["DB06826"],"chEBI":["39455"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1201721","drugType":"Unknown","blackBoxWarning":false,"name":"IODINE POVACRYLEX","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Duraprep copolymer"],"synonyms":["Iodine povacrylex"],"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2006."}
{"id":"CHEMBL1221561","canonicalSmiles":"CN1c2c([nH]c(N)nc2=O)NCC1CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"ZNOVTXRBGFNYRX-ABLWVSNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221561","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04789"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1222035","canonicalSmiles":"CCCCN(C)C(=O)CCCCCCCCCC[C@@H]1Cc2cc(O)ccc2[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21","inchiKey":"BVVFOLSZMQVDKV-KXQIQQEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICI-164384","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ICI-164384"],"crossReferences":{"drugbank":["DB03860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231277","canonicalSmiles":"O=C(O)[C@@H](Cc1ccc2c(c1)OCO2)[C@H](Cc1ccc2c(c1)OCO2)C(=O)O","inchiKey":"FFYBYVPVYLMLAR-KBPBESRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231277","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232313","canonicalSmiles":"C/C(=C/C=C/[C@@H](C)C(=O)O)[C@H]1CN[C@H](C(=O)O)[C@H]1CC(=O)O","inchiKey":"VZFRNCSOCOPNDB-AOKDLOFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOMOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Domoic Acid"],"crossReferences":{"PubChem":["14719311","26751666"],"drugbank":["DB02852"],"chEBI":["34727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233772","canonicalSmiles":"O=C(CN(CCO)S(=O)(=O)c1ccc(-c2ccccc2)cc1)NO","inchiKey":"QQDWEVONJRXVDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233772","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL125386","canonicalSmiles":"NC(=O)c1cn([C@@H](CO)CCn2ccc3ccc(NC(=O)NCc4ccccc4)cc32)cn1","inchiKey":"KCCUBLLGAMGDJL-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL125386","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02830"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1282","canonicalSmiles":"CC(C)Cn1cnc2c(N)nc3ccccc3c21","inchiKey":"DOUYETYNHWVLEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IMIQUIMOD","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldara","Imiquimod","Zyclara"],"synonyms":["Aldara","Imiquimod","NSC-369100","NSC-759651","R-837","S-26308","S26308"],"crossReferences":{"DailyMed":["imiquimod"],"PubChem":["144204536","170464691","174006731","26752301","865810"],"Wikipedia":["Imiquimod"],"drugbank":["DB00724"],"chEBI":["36704"]},"linkedTargets":{"rows":["ENSG00000196664"],"count":1},"linkedDiseases":{"rows":["MONDO_0040677","EFO_1002023","EFO_0000756","EFO_1001951","EFO_0007147","EFO_0000565","MONDO_0002974","EFO_0000389","EFO_1000720","EFO_0005046","EFO_0001668","EFO_1000028","EFO_1000166","MONDO_0021054","EFO_0000220","MONDO_0008170","EFO_0002939","EFO_1001968","EFO_0004197","MONDO_0008315","EFO_0002496","EFO_1000026","MONDO_0021639","EFO_0001422","EFO_0009260","EFO_0001061","EFO_0004192","EFO_0003868","EFO_0007328","EFO_0003835","EFO_1000172","MONDO_0100342","MONDO_0015686","EFO_0002913","MONDO_0007254","EFO_0002627","EFO_1002048","MONDO_0002158","MONDO_0022394","MONDO_0024474","MONDO_0001657","EFO_0000673","EFO_1001361","EFO_0000326","EFO_0004212","EFO_0002499","EFO_0004193","EFO_0000707","EFO_1000635","EFO_1000249","MONDO_0021582","EFO_0005222","MONDO_0005341","MONDO_0023619","EFO_0003060","MONDO_0002102","EFO_0000311","Orphanet_624","EFO_0000095","EFO_0000763","MONDO_0024880","EFO_0000519","MONDO_0024475"],"count":63},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 5 approved and 46 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1315867","canonicalSmiles":"CC(C)(C)NCC(O)c1cc(O)cc(O)c1.CC(C)(C)NCC(O)c1cc(O)cc(O)c1.O=S(=O)(O)O","inchiKey":"KFVSLSTULZVNPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TERBUTALINE SULFATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1760","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brethaire","Brethine","Bricanyl","Bricanyl sa","Monovent","Monovent sa","Terbasmin","Terbutaline sulfate"],"synonyms":["KWD 2019","KWD-2019","NSC-757336","Terbutaline sulfate","Terbutaline sulphate"],"crossReferences":{"DailyMed":["terbutaline%20sulfate"],"PubChem":["144204153","170464990","50107039"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0009661","MONDO_0004979","EFO_0000341","HP_0025428"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1320667","canonicalSmiles":"O=C(O)CC1CC(c2ccccc2)=NO1","inchiKey":"MUFJHYRCIHHATF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VGX-1027","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GIT 27","GIT-027","VGX 1027","VGX-1027","Vgx-1027","Zenuzolac"],"crossReferences":{"PubChem":["90340977"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL132376","canonicalSmiles":"OC[C@H]1O[C@@H](S)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"JUSMHIGDXPKSID-DVKNGEFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL132376","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03859"],"chEBI":["42896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1400561","canonicalSmiles":"CCC(C(N)=O)N1CCCC1=O","inchiKey":"HPHUVLMMVZITSG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIRACETAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etiracetam","Levetiracetam racemic mixture","UCB-6474"],"crossReferences":{"PubChem":["144205826","170464988","29217728"],"drugbank":["DB11868"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1465","canonicalSmiles":"CCC(c1ccccc1)c1c(O)c2ccccc2oc1=O","inchiKey":"DQDAYGNAKTZFIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENPROCOUMON","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Liquamar","Marcoumar"],"synonyms":["BS-7565","Fencumar","Marcumar","Phenprocoumarol","Phenprocoumarole","Phenprocoumon","Phenprocumone","RO-1-4849"],"crossReferences":{"Wikipedia":["Phenprocoumon"],"drugbank":["DB00946"],"chEBI":["50438"]},"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0000756","EFO_0003907","HP_0004419","HP_0004936"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for recurrent thrombophlebitis and has 3 investigational indications."}
{"id":"CHEMBL1618018","canonicalSmiles":"CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2","inchiKey":"ZTVIKZXZYLEVOL-MCOXGKPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HOMATROPINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Homatropine"],"crossReferences":{"PubChem":["144206655"],"drugbank":["DB11181"],"chEBI":["5747"]},"childChemblIds":["CHEMBL1319362"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL175","canonicalSmiles":"CC(C)Cc1ccc([C@H](C)C(=O)O)cc1","inchiKey":"HEFNNWSXXWATRW-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXIBUPROFEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Seractil"],"synonyms":["(s)-ibuprofen","Dexibuprofen","IBU-TAB","NSC-759814","Neoprofen","Rufen","S-ibuprofen"],"crossReferences":{"PubChem":["11111293","11111294","11112775","144206692","47193724","50100253","50106464","85231335","90340840"],"Wikipedia":["Dexibuprofen"],"drugbank":["DB09213"],"chEBI":["43415"]},"childChemblIds":["CHEMBL1778537"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1000786","HP_0001945","EFO_0004616","EFO_0003843","EFO_0005755"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 2 investigational indications."}
{"id":"CHEMBL1779710","canonicalSmiles":"CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F","inchiKey":"LCDDAGSJHKEABN-MLGOLLRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVOGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DA-1229","DA1229","Da-1229","Evogliptin"],"crossReferences":{"drugbank":["DB12625"]},"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0001410","EFO_0009531","MONDO_0005148","EFO_0000400"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1800955","canonicalSmiles":"COC(=O)N1CCN(Cc2cccc(NC(=O)Nc3ccc(C)nc3)c2F)CC1","inchiKey":"RFUBTTPMWSKEIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMECAMTIV MECARBIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CK-1827452","Omecamtiv mecarbil"],"crossReferences":{"PubChem":["174007336"],"drugbank":["DB11816"]},"linkedTargets":{"rows":["ENSG00000197616","ENSG00000160808","ENSG00000111245","ENSG00000106631","ENSG00000078814","ENSG00000092054","ENSG00000198336"],"count":7},"linkedDiseases":{"rows":["HP_0012664","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL182260","canonicalSmiles":"NS(=O)(=O)c1ccc(Nc2cn3cc(C(=O)c4c(Cl)cccc4Cl)ccc3n2)cc1","inchiKey":"UQAWGIKJINAKIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL182260","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04607"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190201","canonicalSmiles":"COc1ccc(-c2oc3ncnc(NCCO)c3c2-c2ccc(OC)cc2)cc1","inchiKey":"ARBUGBBNEFAECO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190201","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08392"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908361","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NC[C@H](CNc1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])cc1)N2C=O.[Ca+2]","inchiKey":"KVUAALJSMIVURS-QNTKWALQSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOLEUCOVORIN CALCIUM","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1908841","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fusilev","Levoleucovorin calcium"],"synonyms":["CL 307,782","CL-307782","Calcium (6s)-folinate","Calcium levofolinate","Calcium levofolinate (6s,l)","Elvorine","Folinic acid l-form calcium salt","Isovorin","Levofolinate calcium","Levoleucovorin calcium"],"crossReferences":{"DailyMed":["levoleucovorin%20calcium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for colorectal adenocarcinoma and osteosarcoma and has 5 investigational indications."}
{"id":"CHEMBL2057236","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)[C@@H]5CCCN5C)cc(F)c4C[C@H]3C[C@@H]12","inchiKey":"IXMIZHVJXGKPJI-HMFHYXQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TP-271","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tp-271"],"crossReferences":{"drugbank":["DB15040"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL206646","canonicalSmiles":"O=C(/C=C/c1ccc(O)c(O)c1)NCCc1ccc(O)cc1","inchiKey":"VSHUQLRHTJOKTA-XBXARRHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Trans-N-Caffeoyltyramine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trans-N-Caffeoyltyramine"],"crossReferences":{"drugbank":["DB08754"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104457","canonicalSmiles":"CC(=O)NC1CCSC1=O","inchiKey":"NRFJZTXWLKPZAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CITIOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Citiolone","NSC-22878"],"crossReferences":{"PubChem":["144204941","144206897","170466625"],"drugbank":["DB13442"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104819","canonicalSmiles":"N#CC(c1ccc(F)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl","inchiKey":"XQKYUBTUOHHNDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LETRAZURIL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Letrazuril"],"crossReferences":{"drugbank":["DB12663"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105902","canonicalSmiles":"COc1ccc([N-]S(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F.[Na+]","inchiKey":"UWPXRVDIKGZQQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BATABULIN SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL79280","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Batabulin sodium","T-138067 SODIUM","T138067-SODIUM"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105910","canonicalSmiles":"CC(COc1ccccc1Cc1ccccc1)N1CCCCC1","inchiKey":"JTUQXGZRVLWBCR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENPROPERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASA 158/5 [AS PHOSPHATE]","Benproperine","Benproperine phosphate","Cofrel"],"crossReferences":{"drugbank":["DB13309"]},"childChemblIds":["CHEMBL4544020"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107354","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC.O.[Na+]","inchiKey":"SARBMGXGWXCXFW-GJHVZSAVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MIFAMURTIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111100","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CGP-19835","L-MTP-PE","Mifamurtide","Mifamurtide sodium hydrate","Mifamurtide sodium salt monohydrate","Sodium mifamurtide"],"linkedTargets":{"rows":["ENSG00000167207"],"count":1},"linkedDiseases":{"rows":["EFO_0000637"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2108332","drugType":"Gene","blackBoxWarning":false,"name":"BEPERMINOGENE PERPLASMID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Beperminogene perplasmid"],"description":"Gene drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108481","drugType":"Unknown","blackBoxWarning":false,"name":"ANCROD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Venacil"],"synonyms":["Acc-c","Ancrod","Arvin","Arwin","Ec 3.4.21.74","Protein c activator","Proteinase, agkistrodon serine","Venombin-a","Viprinex"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108758","drugType":"Small molecule","blackBoxWarning":false,"name":"PEPPERMINT OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Apercap","Colomint","Mintec","Obbekjaers"],"synonyms":["BT MINT 995888","FEMA NO. 2848","Mentha x piperita oil","Peppermint oil","Peppermint volatile oil"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108813","drugType":"Unknown","blackBoxWarning":false,"name":"WAX, EMULSIFYING","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Buff","Coconut oil","Emulfin","Emulsif","Epaderm","H.e.b.","Lanette wax","Lanette wax sx"],"synonyms":["Coconut oil, unhydrogenated","Emulsifying wax","Oil, coconut","Oil,cocnt","Wax, emulsifying"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109330","drugType":"Antibody","blackBoxWarning":false,"name":"IC14","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atibuclimab","IC-14","IC14","Ic14"],"linkedTargets":{"rows":["ENSG00000170458"],"count":1},"linkedDiseases":{"rows":["EFO_0005547","MONDO_0100096","MONDO_0100130","MONDO_0004976","EFO_1000637"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109361","drugType":"Antibody","blackBoxWarning":false,"name":"PEMTUMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Theragyn"],"synonyms":["Pemtumomab","RG-1549"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2109365","drugType":"Antibody","blackBoxWarning":false,"name":"HUPAM4","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUPAM4"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109389","drugType":"Antibody","blackBoxWarning":false,"name":"IMGATUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GA-201","GA201","HUMA-B","HUMAB","HuMAB<EGFR>","Imgatuzumab","RG7160","RO-5083945","RO5083945"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000203747"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","EFO_1001927","EFO_0003060","EFO_1001951"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109492","drugType":"Antibody","blackBoxWarning":false,"name":"MDX-1411","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDX-1411","Mdx-1411"],"linkedTargets":{"rows":["ENSG00000125726"],"count":1},"linkedDiseases":{"rows":["EFO_1001469"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109593","drugType":"Antibody","blackBoxWarning":false,"name":"FGI-101-1A6","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FGI-101-1A6","Fgi-101-1a6"],"linkedTargets":{"rows":["ENSG00000074319"],"count":1},"linkedDiseases":{"rows":["EFO_0007328"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109625","drugType":"Antibody","blackBoxWarning":false,"name":"MGAWN1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGAWN1","Mgawn1"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL216647","canonicalSmiles":"CC(C)(NC(=O)c1ccc2c(C3CCCCC3)c3n(c2c1)CCOc1ccccc1-3)C(=O)O","inchiKey":"LNQWELVSNCYKDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216647","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08031"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2178578","canonicalSmiles":"CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1","inchiKey":"JRWROCIMSDXGOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERCIRNON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCX-282-B","CCX282","GSK-1605786","GSK1605786","Vercirnon","Verecimon"],"crossReferences":{"drugbank":["DB15250"]},"childChemblIds":["CHEMBL3039505"],"linkedTargets":{"rows":["ENSG00000173585"],"count":1},"linkedDiseases":{"rows":["EFO_0001060","EFO_0000729","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL219321","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OS(N)(=O)=O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"YXYXCSOJKUAPJI-ZBRFXRBCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E2MATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Estradiol-3-O-Sulfamate"],"crossReferences":{"drugbank":["DB06597"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222419","canonicalSmiles":"COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC","inchiKey":"UHCHLTQBLNUYRT-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-237701A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK237701A"],"crossReferences":{"drugbank":["DB07471"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2392545","canonicalSmiles":"COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc1ncc2c(n1)N(C1CCCC1)CC(F)(F)C(=O)N2C","inchiKey":"GWRSATNRNFYMDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-960","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-960","TAK960","Tak-960"],"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL267345","canonicalSmiles":"C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2","inchiKey":"APKFDSVGJQXUKY-INPOYWNPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMPHOTERICIN B","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abelcet","Ambisome","Amophotericin B","Ampho-moronal","Amphotec","Amphotercin B","Amphotericin b","Amphotericine B","Amphotericitin B","Amphotreicin B","Ampotericin B","Fungilin","Fungilin in orabase","Fungizone"],"synonyms":["Ambil","Amphotericin","Amphotericin b","Amphotericin b deoxycholate","Amphotericin b lipid complex","Amphotericin b liposomal","Amphotericin b liposomal complex","Amphotericin b liposome","Amphotericin b, liposome","Amphotericinum b","Amphotocerin","Halizon","NSC-527017"],"crossReferences":{"DailyMed":["amphotericin%20b"],"PubChem":["144204578","144209682","17389549"],"Wikipedia":["Amphotericin_B"],"drugbank":["DB00681"],"chEBI":["2682"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 10 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL275339","canonicalSmiles":"Oc1ccc(-n2ccnc2)cc1","inchiKey":"CYKCUAPYWQDIKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL275339","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08214"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL276711","canonicalSmiles":"Cc1cc(C)c(/C=C2\\C(=O)Nc3ccccc32)[nH]1","inchiKey":"WUWDLXZGHZSWQZ-WQLSENKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEMAXANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-696819","SU-5416","SU005416","SU5416","Semaxanib","Semaxinib","Su-5416"],"crossReferences":{"PubChem":["124891688","49674962","50107014","50107016","525180","56322916","90341564"],"Wikipedia":["Semaxanib"],"drugbank":["DB06436"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000157404"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","EFO_0000365","EFO_0000756","EFO_0000681","MONDO_0007254","EFO_1000657","MONDO_0021063","MONDO_0008315","EFO_1001951","EFO_0000588","MONDO_0002974","EFO_0000389","MONDO_0002367","EFO_0001378","EFO_0000691","EFO_1000158"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 17 investigational indications."}
{"id":"CHEMBL284104","canonicalSmiles":"O=C(O)c1cccc(C(=O)O)n1","inchiKey":"WJJMNDUMQPNECX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPICOLINIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dipicolinic Acid"],"crossReferences":{"PubChem":["144211446","863941"],"Wikipedia":["Dipicolinic_acid"],"drugbank":["DB04267"],"chEBI":["46837"]},"childChemblIds":["CHEMBL4521011","CHEMBL177801"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289288","canonicalSmiles":"C[C@](O)(C(=O)Nc1cccc2c1C(=O)c1sccc1CS2(=O)=O)C(F)(F)F","inchiKey":"NAFSYPCVPLWHFY-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL289288","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB05498"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL293492","canonicalSmiles":"O=C/C=C/c1ccccc1","inchiKey":"KJPRLNWUNMBNBZ-QPJJXVBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINNAMALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-phenylacrolein","Abion ca","Cinnamal","Cinnamaldehyde","Cinnamic aldehyde","FEMA NO. 2286","NSC-16935","NSC-40346","XC-800","Zimtaldehyde"],"crossReferences":{"PubChem":["144204695","144209002","144213588","17389103","17389104","29215112","85272553"],"Wikipedia":["Cinnamaldehyde"],"drugbank":["DB14184"],"chEBI":["16731"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295619","canonicalSmiles":"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2SCC4)CC1","inchiKey":"NJCJBUHJQLFDSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MF 934","NSC-759835","Rufloxacin"],"crossReferences":{"PubChem":["26719881","49681571","50105208"],"Wikipedia":["Rufloxacin"],"drugbank":["DB13772"],"chEBI":["8909"]},"childChemblIds":["CHEMBL1385206"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3039539","drugType":"Antibody","blackBoxWarning":false,"name":"OTLERTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Otlertuzumab","TRU-016"],"linkedTargets":{"rows":["ENSG00000104894"],"count":1},"linkedDiseases":{"rows":["EFO_0000095"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3039588","canonicalSmiles":"NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2C[C@H](OC(=O)NCCN)CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O.N[C@@H](CC(=O)O)C(=O)O.N[C@@H](CC(=O)O)C(=O)O","inchiKey":"NEEFMPSSNFRRNC-PPCPDXGKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"PASIREOTIDE DIASPARTATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3039583","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Signifor"],"synonyms":["Pasireotide (as diaspartate)","Pasireotide diaspartate"],"crossReferences":{"DailyMed":["pasireotide%20diaspartate"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 2012."}
{"id":"CHEMBL3113734","canonicalSmiles":"Cc1ccc(O)c(C(=O)N[C@H]2CC[C@@H](NC(=O)c3cc(F)cnc3Oc3ccc(F)c(F)c3)CC2)c1","inchiKey":"OHIUQAZROSYCMC-CALCHBBNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UK-500001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Uk-500,001","Uk-500001"],"crossReferences":{"drugbank":["DB12837"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3126832","canonicalSmiles":"CC(C)[C@H]1NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C)C(=O)N2)OC(=O)C[C@@H]1O","inchiKey":"XFLBOEMFLGLWFF-HDXRNPEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OBP-801","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Obp-801","Spiruchostatin a","YM-753"],"crossReferences":{"drugbank":["DB12279"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3219124","canonicalSmiles":"COC[C@H](C)Oc1cc(Oc2cnc(C(=O)N3CCC3)cn2)cc(C(=O)Nc2cnc(C)cn2)c1","inchiKey":"FJEJHJINOKKDCW-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-1656","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD1656","Azd 1656","Azd-1656","Azd1656"],"crossReferences":{"drugbank":["DB14810"]},"linkedTargets":{"rows":["ENSG00000106633"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","MONDO_0005147","MONDO_0005148"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL35033","canonicalSmiles":"CCOCn1c(Cc2ccccc2)c(C(C)C)c(=O)[nH]c1=O","inchiKey":"MLILORUFDVLTSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMIVIRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Coactinon"],"synonyms":["Emivirine","MKC-442"],"crossReferences":{"Wikipedia":["Emivirine"],"drugbank":["DB08188"],"chEBI":["44143"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3544995","drugType":"Cell","blackBoxWarning":false,"name":"STAPULDENCEL-T","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DCVAC/PCa","Stapuldencel-t"],"description":"Cell drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3545169","canonicalSmiles":"CC(C)(C)OC(=O)NCCN1CC2CN(CCOc3ccc(C#N)cc3F)CC(C1)O2","inchiKey":"BLLNYXOLLAVTRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD1305","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd 1305","Azd-1305","Azd1305"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001","ENSG00000055118"],"count":6},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545300","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-459632","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cp-459632"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545378","canonicalSmiles":"Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)c4cc(Cl)ccc4F)C3)n2)n[nH]1","inchiKey":"SLUHYAXFRJQTGB-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-6592","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-6592","VX-667"],"linkedTargets":{"rows":["ENSG00000087586","ENSG00000178999","ENSG00000105146"],"count":3},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL355200","canonicalSmiles":"C#Cc1cnc(O)nc1O","inchiKey":"JOZGNYDSEBIJDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENILURACIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["776-C-85","776C85","Eniluracil"],"crossReferences":{"drugbank":["DB03516"]},"linkedTargets":{"rows":["ENSG00000188641"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0000365","EFO_1000657","MONDO_0007254","EFO_0000574","MONDO_0021063","EFO_0000311","EFO_1001951"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3644587","canonicalSmiles":"O=c1[nH]nc2c3c(cccc13)N=C(CN1Cc3ccccc3C1)N2","inchiKey":"JLFSBHQQXIAQEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2X-121","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2X-121","2x-121","E-7449","E7449","Parp inhibitor 2x-121","Stenoparib"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000173273","ENSG00000107854","ENSG00000129484"],"count":4},"linkedDiseases":{"rows":["MONDO_0008170","MONDO_0007254","EFO_0000305"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3655081","canonicalSmiles":"CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1","inchiKey":"IUEWXNHSKRWHDY-PHIMTYICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABROCITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abrocitinib","PF-04965842","Pf-04965842"],"crossReferences":{"drugbank":["DB14973"]},"linkedTargets":{"rows":["ENSG00000162434"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001421","EFO_1001890","EFO_0000676","EFO_0000274"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707225","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2798745","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk-2798745","Gsk2798745"],"linkedTargets":{"rows":["ENSG00000111199"],"count":1},"linkedDiseases":{"rows":["MONDO_0003005","HP_0012735","EFO_0003144","EFO_1001134","EFO_0000373"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3707309","canonicalSmiles":"CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C(C)C.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F","inchiKey":"IBMWAUVJJROIMB-IWEBAUSJSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FEXAPOTIDE TRIFLUTATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3545061","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fexapotide triflutate","NX-1207","NX-1207 TRIFLUOROACETATE"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707333","canonicalSmiles":"O[B-]1(O)OO[B-](O)(O)OO1.[Na+].[Na+]","inchiKey":"JBUKJLNBQDQXLI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PERBORATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3707334","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bocasan"],"synonyms":["Dexol","Sodium perborate"],"crossReferences":{"DrugCentral":["4777"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for infection."}
{"id":"CHEMBL3716365","canonicalSmiles":"O=c1nc(OC[C@@H]2COCCO2)cc2n1CCc1cc(C#CC3CC3)ccc1-2","inchiKey":"IRBAWVGZNJIROV-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLPG-1205","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glpg-1205","Glpg1205"],"crossReferences":{"drugbank":["DB15346"]},"linkedTargets":{"rows":["ENSG00000139572"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000768"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL375112","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2cc3cc(Cl)ccc3[nH]2)C1=O","inchiKey":"BHNMMFGOJRIAEZ-LRDDRELGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL375112","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07848"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833393","drugType":"Antibody","blackBoxWarning":true,"name":"EMICIZUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hemlibra"],"synonyms":["ACE-910","ACE910","Emicizumab","Emicizumab-kxwh"],"crossReferences":{"DailyMed":["emicizumab"]},"linkedTargets":{"rows":["ENSG00000126218","ENSG00000101981"],"count":2},"linkedDiseases":{"rows":["MP_0001914","Orphanet_169802","Orphanet_98878"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for hemorrhage and hemophilia a. This drug has a black box warning from the FDA."}
{"id":"CHEMBL38681","canonicalSmiles":"Clc1ccc2c(c1Cl)CNCCC2","inchiKey":"IADAQXMUWITWNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-134046","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-134046"],"crossReferences":{"drugbank":["DB04273"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989640","canonicalSmiles":"O.O.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Mg+2]","inchiKey":"HJWFTNWQKDPLAS-SYAJEJNSSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM GLUCONATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL2107145","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Almora"],"synonyms":["E-580(magnesium gluconate)","Ins no.580(magnesium gluconate)","Ins-580(magnesium gluconate)","Magnesium (as gluconate)","Magnesium gluconate","Magnesium gluconate,dihydrate","Magnesium gluconicum"],"crossReferences":{"drugbank":["DB13749"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL3989698","canonicalSmiles":"N[C@@H]1C[C@H]1c1ccccc1.N[C@H]1C[C@@H]1c1ccccc1.O=S(=O)(O)O","inchiKey":"BKPRVQDIOGQWTG-ICOOEGOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRANYLCYPROMINE SULFATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3989843","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pamate","Parnate","Parstelin","Tranylcypromine sulfate"],"synonyms":["NSC-757342","Tranylcypromine sulfate","Tranylcypromine sulphate"],"crossReferences":{"DailyMed":["tranylcypromine%20sulfate"]},"linkedTargets":{"rows":["ENSG00000189221","ENSG00000069535"],"count":2},"linkedDiseases":{"rows":["MONDO_0002009","EFO_1002014"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for melancholia and major depressive disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989947","canonicalSmiles":"CCCCCCCCCCCCCCOc1ccc(C(=O)OCC(=O)N(C)CC(=O)OCC)o1","inchiKey":"FYJLDICZGDFWKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLUMACOSTAT GLASARETIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DRM-01B","DRM01B","DRMO1B","Olumacostat glasaretil"],"crossReferences":{"drugbank":["DB12642"]},"linkedTargets":{"rows":["ENSG00000278540","ENSG00000076555"],"count":2},"linkedDiseases":{"rows":["EFO_0003894"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989994","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"COBOMARSEN SODIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cobomarsen sodium","M11667","MRG-106"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3990042","drugType":"Antibody","blackBoxWarning":false,"name":"GOSURANEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB092","BMS-986168","BMS-986168-01","Biib-092","Gosuranemab","IPN-007"],"linkedTargets":{"rows":["ENSG00000186868"],"count":1},"linkedDiseases":{"rows":["Orphanet_683","MONDO_0004975","Orphanet_240071"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4091801","canonicalSmiles":"CCN1[C@@H](C(=O)NC23CCC(C(=O)O)(CC2)CC3)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2","inchiKey":"YJCZPJQGFSSFOL-MNZPCBJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APG115","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apg115"],"linkedTargets":{"rows":["ENSG00000141510","ENSG00000135679"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_1001779","EFO_0004289","MONDO_0004669","EFO_0000574","EFO_0000222","EFO_0000569"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL416526","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(O)cc12","inchiKey":"VTTONGPRPXSUTJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFOTENINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bufotenine"],"crossReferences":{"PubChem":["124954092","144206443"],"Wikipedia":["Bufotenin"],"drugbank":["DB01445"],"chEBI":["3210"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4212531","canonicalSmiles":"CC(C)(CO)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cn3)c2)c2cnc(N)nc21","inchiKey":"BPIWZDNVMQQBQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06273340","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF06273340","Pf-06273340"],"crossReferences":{"drugbank":["DB12269"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4296719","canonicalSmiles":"O=C(CN[C@@H]1CCNC1)N1CCC[C@H]1B(O)O","inchiKey":"DVJAMEIQRSHVKC-BDAKNGLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DUTOGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dutogliptin","PHX1149","Phx1149"],"crossReferences":{"drugbank":["DB11723"]},"childChemblIds":["CHEMBL4297203"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 1 investigational indication."}
{"id":"CHEMBL4297277","canonicalSmiles":"CC(/C=C1\\SC(=S)N(CC(=O)O)C1=O)=C\\c1ccccc1.CC(/C=C1\\SC(=S)N(CC(=O)[O-])C1=O)=C\\c1ccccc1.C[N+](C)(C)CCO","inchiKey":"WKSNHZZSMLFYFI-UROVXFGGSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DIEPALRESTAT CHOLINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL56337","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diepalrestat choline"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297282","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1sc(-c2ncco2)nc1-c1ccccc1)C1CCCCC1","inchiKey":"HSHPBORBOJIXSQ-HARLFGEKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GDC-0917","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CUDC-427","Cudc 427","Cudc-427","Gdc-0917"],"crossReferences":{"drugbank":["DB12336"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297284","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](O)CC1=C[C@@H]3O","inchiKey":"JJKOQZHWYLMASZ-FJWDNACWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HE3286","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HE 3286","HE-3286","HE3286","He3286","Triolex"],"crossReferences":{"drugbank":["DB05212"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297415","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTIMONY CATION (5+)","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antimony cation (5+)","Pentavalent antimony"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297466","canonicalSmiles":"CC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H]1CSSC[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(N)=O)C(=O)O)NC(=O)[C@@H](CCC(N)=O)NC1=O","inchiKey":"MDQMFOHHSFMREL-YIYMUJAPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GO-203-2C","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GO-203-2C","Go-203-2c"],"crossReferences":{"drugbank":["DB15008"]},"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297538","canonicalSmiles":"CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](CN2CCc3ncc(C(F)(F)F)cc3C2)(C(C)C)C1","inchiKey":"UNVWTBOGMHPKJM-CWKRKGSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0812","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-0812","Mk0812"],"crossReferences":{"drugbank":["DB11990"]},"linkedTargets":{"rows":["ENSG00000121807"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0003929"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297711","drugType":"Protein","blackBoxWarning":false,"name":"BULEVIRTIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hepcludextm","Myrcludex"],"synonyms":["915207G","Bulevirtide","Hepcludex"],"linkedTargets":{"rows":["ENSG00000100652"],"count":1},"linkedDiseases":{"rows":["EFO_0008496","EFO_0000763"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for viral disease and has 1 investigational indication."}
{"id":"CHEMBL4298103","drugType":"Unknown","blackBoxWarning":false,"name":"CINHYALURONATE SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinhyaluronate sodium","SI-614","SODIUM SALT OF HYALURONIC ACID PARTLY (12%) AMIDIFIED WITH 3-((3-PHENYLPROP-2-ENOYL)OXY)PROPAN-1-AMINE","Si-614"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4442620","canonicalSmiles":"C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(S(=N)(=O)C3CC3)cc2)ncc1C(F)(F)F","inchiKey":"UELYDGOOJPRWGF-MFOHZAOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RONICICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY10-00394","Bay 1000394","Bay-1000394","Roniciclib"],"linkedTargets":{"rows":["ENSG00000250506","ENSG00000156345","ENSG00000123374","ENSG00000134058","ENSG00000164885","ENSG00000135446","ENSG00000155111","ENSG00000136807","ENSG00000059758","ENSG00000105810","ENSG00000167258","ENSG00000138395","ENSG00000058091","ENSG00000248333","ENSG00000132964","ENSG00000117266","ENSG00000065883","ENSG00000102225","ENSG00000170312","ENSG00000185324"],"count":20},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000702","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4518483","canonicalSmiles":"N#Cc1ccc(COc2cccc(C3CCN(Cc4nc5ccc(C(=O)O)cc5n4C[C@@H]4CCO4)CC3)n2)c(F)c1","inchiKey":"HYBAKUMPISVZQP-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DANUGLIPRON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Danuglipron","PF-06882961","Pf-06882961"],"childChemblIds":["CHEMBL4650218"],"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["EFO_0001421","EFO_0001073","MONDO_0005148"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594402","canonicalSmiles":"CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(OCCOc5ccc6c7c5O[C@@H]5[C@]78CCN(CC7CC7)[C@H](C6)[C@]86CC[C@@]5(OC)[C@@H]([C@](C)(O)C(C)(C)C)C6)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"LEQOVFCHMOTJKU-WJVXOHEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORP-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buprenorphine dimer","Orp-101"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0000555"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594480","drugType":"Unknown","blackBoxWarning":false,"name":"L-DOS47","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-dos47"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594579","drugType":"Antibody","blackBoxWarning":false,"name":"FELZARTAMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Felzartamab","MOR-03087","MOR-202","MOR03087","Mor03087","Mor202","TJ-202","TJ202"],"linkedTargets":{"rows":["ENSG00000004468"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0004254","EFO_0002690","EFO_0001378","MONDO_0002462","EFO_0004194"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4650482","drugType":"Antibody","blackBoxWarning":false,"name":"PIMIVALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JTX-4014","Jtx 4014","Jtx-4014","Pimivalimab"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL474024","canonicalSmiles":"O=C(N/N=C/c1cc(Br)c(O)c(Br)c1O)c1ccc(Cl)cc1","inchiKey":"ZDMUFSJTENTNDA-NGYBGAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL474024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06950"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802165","drugType":"Antibody","blackBoxWarning":false,"name":"BEMARITUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bemarituzumab","FPA-144"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL506","canonicalSmiles":"COc1cc(NC(C)CCCN)c2ncccc2c1","inchiKey":"INDBQLZJXZLFIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PRIMAQUINE","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Kanaprim","Maliride","NSC-27296","Neo-quipenyl","Primachin","Primaquine","SN-13272","WR-2975"],"crossReferences":{"DailyMed":["primaquine%20phosphate"],"PubChem":["174006623","24715072","24715073","50123426"],"Wikipedia":["Primaquine"],"drugbank":["DB01087"],"chEBI":["8405"]},"childChemblIds":["CHEMBL994","CHEMBL3217110","CHEMBL43128"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and is indicated for malaria and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL506247","canonicalSmiles":"O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1","inchiKey":"LRBQNJMCXXYXIU-PPKXGCFTSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"TANNIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Asian holly oak nutgall","E181","FEMA NO. 3042","Gallotannic acid","Gallotannin","NSC-656273","NSC-758670","Tannic acid","Tannic acid, unspecified","Tannicum acidum"],"crossReferences":{"DrugCentral":["5039"],"PubChem":["124896727","144204975","144210399","57260395"],"TG-GATEs":["93"],"Wikipedia":["Tannic_acid"],"chEBI":["81066"]},"description":"Unknown drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL517231","canonicalSmiles":"C#C[C@]1(CO)O[C@@H](n2cnc3c(N)nc(F)nc32)C[C@@H]1O","inchiKey":"IKKXOSBHLYMWAE-QRPMWFLTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISLATRAVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Islatravir","MK-8591","Mk-8591"],"crossReferences":{"drugbank":["DB15653"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL518800","canonicalSmiles":"CC[C@H](CO)Nc1nc(NCc2ccc(-c3ccccn3)cc2)c2ncn(C(C)C)c2n1","inchiKey":"HOCBJBNQIQQQGT-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL518800","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08463"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL529888","canonicalSmiles":"Cc1ccc(S(=O)(=O)NC(=O)N[C@H]2[C@H]3CC[C@@](C)([C@H]2O)C3(C)C)cc1","inchiKey":"RMTYNAPTNBJHQI-LLDVTBCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLIBORNURIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glutril"],"synonyms":["Glibornuride","RO 6-4563","RO-6-4563","RO-64563"],"crossReferences":{"drugbank":["DB08962"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus."}
{"id":"CHEMBL549748","canonicalSmiles":"O=C(O)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1","inchiKey":"PPJYSSNKSXAVDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levothyroxine sodium impurity, t4-acetic acid-","T4-acetic acid","Tetrac","Tetraiodothyroacetic acid"],"crossReferences":{"PubChem":["144213801"],"drugbank":["DB01751"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL561371","canonicalSmiles":"CCCCCCCC/C(=C\\CCCCCCCC(=O)O)[N+](=O)[O-]","inchiKey":"WRADPCFZZWXOTI-BMRADRMJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CXA-10","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CXA-10","Cxa-10","E-10-no2-18:1","Oa-no2"],"crossReferences":{"drugbank":["DB15026"],"chEBI":["86285"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL561660","canonicalSmiles":"NC(=O)c1cnc2ccn(S(=O)(=O)c3ccccc3[N+](=O)[O-])c2c1","inchiKey":"USLOIFPDNUDIEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561660","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08791"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566757","canonicalSmiles":"O=C(/C=C/c1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1","inchiKey":"KPBNHDGDUADAGP-VAWYXSNFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPORINAD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APO 866","APO-866","APO866","Daporinad","FK 866","FK-866","K 22.175"],"crossReferences":{"drugbank":["DB12731"]},"linkedTargets":{"rows":["ENSG00000105835"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000756","EFO_0002913"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL589","canonicalSmiles":"CCCN(CCC)CCc1cccc2c1CC(=O)N2","inchiKey":"UHSKFQJFRQCDBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ROPINIROLE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Requip"],"synonyms":["NSC-758917","Requip","Ropinirole","SK&F 101468"],"crossReferences":{"DailyMed":["ropinirole%20hydrochloride"],"PubChem":["104171231","11111741","144203807","170465139","26750081","90341563"],"Wikipedia":["Ropinirole"],"drugbank":["DB00268"],"chEBI":["8888"]},"childChemblIds":["CHEMBL1200411"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0000289","EFO_0005687","EFO_0002610","EFO_0004714","MONDO_0002009","MONDO_0005180","EFO_0000712","EFO_0009846","EFO_0007319","EFO_0004270"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for parkinson disease and restless legs syndrome and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL607","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCN(C)CC1","inchiKey":"XADCESSVHJOZHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MEPERIDINE","yearOfFirstApproval":1942,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["IDS-NP-001","Isonipecaine","Meperidine","Meperidol","Pethanol","Pethidine","Pethidine dbl","Pethidineter","Renaudin"],"crossReferences":{"DailyMed":["meperidine%20hydrochloride"],"Wikipedia":["Pethidine"],"drugbank":["DB00454"],"chEBI":["6754"]},"childChemblIds":["CHEMBL429713","CHEMBL1701"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","HP_0002140","EFO_0003819","EFO_0003832","EFO_0004273","EFO_0003843","HP_0011868","EFO_0005251"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1942 and is indicated for pain and drug dependence and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL714","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(CO)c1","inchiKey":"NDAUXUAQIAJITI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALBUTEROL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerolin","Aerolin 400","Aerolin auto","Airomir","Airsalb","Albuterol","Asmasal clickhaler","Asmasal spacehaler","Asmaven","Asmavent","Cobutolin","Combivent","Combivent udvs","Ipramol steri-neb","Kentamol","Libetist","Maxivent","Proair Hfa","Proventil","Proventil Hfa","Rimasal","Salamol e-breathe","Salapin","Salbulin novolizer","Salbuvent","Salipraneb","Steri-neb salamol","Ventmax sr","Ventodisks","Ventolin","Ventolin Hfa","Ventolin cr","Ventolin e-breathe","Volmax"],"synonyms":["Accuneb","Albuterol","Combivent","Duoneb","Etinoline","NSC-757417","PROVENTIL-HFA","SCH 13949W","SCH-13949W","Salbutamol","Salbutamolum","Ventoline","Volmax"],"crossReferences":{"DailyMed":["albuterol","albuterol%20sulfate"],"PubChem":["104171238","144203817","170465034","50104505","90340718","90341530"],"Wikipedia":["Salbutamol"],"drugbank":["DB01001"],"chEBI":["2549"]},"childChemblIds":["CHEMBL1437301","CHEMBL1201026","CHEMBL1441059"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","MONDO_0100130","MONDO_0002009","HP_0012735","EFO_0000768","HP_0002153","EFO_0010638","MONDO_0005271","EFO_1001919","EFO_0000373","Orphanet_538","EFO_0009840","EFO_0009715","HP_0011950","EFO_0009836","Orphanet_365","Orphanet_1764","EFO_1001134","EFO_0010581","MONDO_0100053","EFO_0000400","Orphanet_244","EFO_0009686","MONDO_0005149","Orphanet_275766","EFO_0008590","Orphanet_590","EFO_0000319","EFO_0003818","MONDO_0004784","HP_0006536","EFO_0001072","MONDO_0001208","Orphanet_1480","MONDO_0004979","EFO_0000341","HP_0025428","EFO_0003956"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 27 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL72","canonicalSmiles":"CNCCCN1c2ccccc2CCc2ccccc21","inchiKey":"HCYAFALTSJYZDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESIPRAMINE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Desipramine","Imipramine, demethyl-","Monodemethylimipramine","N-desmethylimipramine","Norimipramine"],"crossReferences":{"DailyMed":["desipramine%20hydrochloride"],"PubChem":["11111066","11111067","174316136","50100220","50104283","90341801"],"Wikipedia":["Desipramine"],"drugbank":["DB01151"],"chEBI":["47781"]},"childChemblIds":["CHEMBL227644","CHEMBL1696"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","HP_0012532","MONDO_0002009","EFO_0004234","EFO_0001358","HP_0003418","Orphanet_778","HP_0011868","EFO_0000311","EFO_0003948","EFO_0003890","MONDO_0002050","Orphanet_35069","EFO_0000702","EFO_0003761","MONDO_0007079","EFO_0003918"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for depressive disorder and unipolar depression and has 13 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL82304","canonicalSmiles":"Cc1cc(CCCOc2c(C)cc(-c3nnn(C)n3)cc2C)on1","inchiKey":"RVZKQTQAFHEOKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL82304","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08713"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL887","canonicalSmiles":"C#CCN[C@@H]1CCc2ccccc21","inchiKey":"RUOKEQAAGRXIBM-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RASAGILINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AGN-1135","Azilect","NSC-759639","Rasagiline","TV-1030"],"crossReferences":{"DailyMed":["rasagiline%20mesylate"],"Wikipedia":["Rasagiline"],"drugbank":["DB01367"],"chEBI":["63620"]},"childChemblIds":["CHEMBL1201142"],"linkedTargets":{"rows":["ENSG00000069535"],"count":1},"linkedDiseases":{"rows":["EFO_1001050","MONDO_0005090","Orphanet_683","MONDO_0005180","MONDO_0004975","MONDO_0004976","EFO_0005773","EFO_0004270"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for parkinson disease and has 5 investigational indications."}
